| pubmed-article:1458626 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1458626 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:1458626 | lifeskim:mentions | umls-concept:C0740083 | lld:lifeskim |
| pubmed-article:1458626 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
| pubmed-article:1458626 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:1458626 | pubmed:dateCreated | 1993-1-8 | lld:pubmed |
| pubmed-article:1458626 | pubmed:abstractText | The records of 23 patients treated by CO2-laser surgery for recurrent glottic carcinoma after radiotherapy were studied retrospectively to assess treatment results and complications. 15 patients (65%) were cured with one or more laser procedures. The remaining 8 underwent a total laryngectomy for a second or third recurrence. One patient (4%) died of disease. No major complications from CO2-laser surgery were encountered. It is concluded that CO2-laser surgery is a safe method of treatment of recurrent glottic carcinoma. | lld:pubmed |
| pubmed-article:1458626 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1458626 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1458626 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1458626 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1458626 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1458626 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:1458626 | pubmed:issn | 0307-7772 | lld:pubmed |
| pubmed-article:1458626 | pubmed:author | pubmed-author:de BoerM FMF | lld:pubmed |
| pubmed-article:1458626 | pubmed:author | pubmed-author:KnegtP PPP | lld:pubmed |
| pubmed-article:1458626 | pubmed:author | pubmed-author:KerrebijnJ... | lld:pubmed |
| pubmed-article:1458626 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1458626 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:1458626 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1458626 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1458626 | pubmed:pagination | 430-2 | lld:pubmed |
| pubmed-article:1458626 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:1458626 | pubmed:meshHeading | pubmed-meshheading:1458626-... | lld:pubmed |
| pubmed-article:1458626 | pubmed:meshHeading | pubmed-meshheading:1458626-... | lld:pubmed |
| pubmed-article:1458626 | pubmed:meshHeading | pubmed-meshheading:1458626-... | lld:pubmed |
| pubmed-article:1458626 | pubmed:meshHeading | pubmed-meshheading:1458626-... | lld:pubmed |
| pubmed-article:1458626 | pubmed:meshHeading | pubmed-meshheading:1458626-... | lld:pubmed |
| pubmed-article:1458626 | pubmed:meshHeading | pubmed-meshheading:1458626-... | lld:pubmed |
| pubmed-article:1458626 | pubmed:meshHeading | pubmed-meshheading:1458626-... | lld:pubmed |
| pubmed-article:1458626 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1458626 | pubmed:articleTitle | CO2-laser treatment of recurrent glottic carcinoma. | lld:pubmed |
| pubmed-article:1458626 | pubmed:affiliation | Department of Otolaryngology/Head and Neck Surgery, University Hospital Rotterdam Dijkzigt, The Netherlands. | lld:pubmed |
| pubmed-article:1458626 | pubmed:publicationType | Journal Article | lld:pubmed |
